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Abstract
Background: Glutathione S-transferases (GSTs) metabolize drugs and xenobiotics. Yet despite high protein sequence
homology, expression of p-class GSTs, the most abundant of the enzymes, varies significantly between species. In mouse
liver, hepatocytes exhibit high mGstp expression, while in human liver, hepatocytes contain little or no hGSTP1 mRNA or
hGSTP1 protein. p-class GSTs are known to be critical determinants of liver responses to drugs and toxins: when treated with
high doses of acetaminophen, mGstp1/2+/+ mice suffer marked liver damage, while mGstp1/22/2 mice escape liver injury.
Methodology/Principal Findings: To more faithfully model the contribution of p-class GSTs to human liver toxicology, we
introduced hGSTP1, with its exons, introns, and flanking sequences, into the germline of mice carrying disrupted mGstp
genes. In the resultant hGSTP1+mGstp1/22/2 strain, p-class GSTs were regulated differently than in wild-type mice. In the
liver, enzyme expression was restricted to bile duct cells, Kupffer cells, macrophages, and endothelial cells, reminiscent of
human liver, while in the prostate, enzyme production was limited to basal epithelial cells, reminiscent of human prostate.
The human patterns of hGSTP1 transgene regulation were accompanied by human patterns of DNA methylation, with
bisulfite genomic sequencing revealing establishment of an unmethylated CpG island sequence encompassing the gene
promoter. Unlike wild-type or mGstp1/22/2 mice, when hGSTP1+mGstp1/22/2 mice were overdosed with acetaminophen,
liver tissues showed limited centrilobular necrosis, suggesting that p-class GSTs may be critical determinants of toxin-
induced hepatocyte injury even when not expressed by hepatocytes.
Conclusions: By recapitulating human p-class GST expression, hGSTP1+mGstp1/22/2 mice may better model human drug
and xenobiotic toxicology.
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Introduction
Cytosolic glutathione S-transferases (GSTs) are encoded by a
superfamily of genes grouped intoa, m, p, s, h, f, and v classes by
primary amino acid sequence [1,2]. The enzymes, which can exist
as homo- or heterodimers of subunit polypeptides, catalyze
reactions involving the conjugation of reduced glutathione
(GSH) to electrophilic substrates. By targeting electrophiles
generated by cytochrome P450s for conjugation with GSH, GSTs
contribute to coordinated drug and xenobiotic metabolism,
promoting the ultimate elimination of potential toxins by the
ATP-dependent glutathione S-conjugate export pump [3]. The p-
class GST, a homodimeric enzyme which was first described as a
placental isoform, has since been found in many different tissues
and is now known to be the most abundant of the GSTs [4]. The
amino acid sequence of p-class GST subunit polypeptides is
remarkably conserved across species, perhaps because the enzymes
have been implicated in a broad array of vital cell and tissue
functions, including xenobiotic metabolism, cell signaling, muta-
gen/carcinogen defense, and antineoplastic drug resistance [5].
Human p-class GSTs are encoded by a single gene, hGSTP1,
while mice have two such genes, mGstp1 and mGstp2. Each of the
genes has 7 exons that encode enzyme subunit polypeptides of 210
amino acids [5]. The degree of protein homology is striking: of the
210 amino acids, 170 (81%) are completely conserved, and
accounting for conserved and semi-conserved substitutions, the
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mGstp1, and mGstp2 also share some common transcriptional
promoter elements, including an AP1 (TGA[C/G]TCA) tran-
scription factor binding site and GC boxes (GGGCGG) permitting
SP1 transcription factor binding just upstream of a TATA box.
hGSTP1 and mGstp2 have two SP1 binding sites; mGstp1 has only
one. For hGSTP1, the AP1 site and at least one of the SP1 sites
must be intact for hGSTP1 transcription to occur [6,7].
Despite the extensive coding sequence homology, the transcrip-
tion promoter regions and introns display little similarity across
species, aside from the AP1 and SP1 sites. hGSTP1 contains several
unique promoter elements that could contribute to transcriptional
regulation, including a pentad B sequence repeated 18 to 21 times
and an overlapping NF-kB and C/EBP site (TTAAGGGAAT-
TTCC). Also noteworthy is the abundance of CpG dinucleotides
(n=39) found between an [ATAAA]n repeat region and the
hGSTP1 transcription start site. These CpGs, which are unmethy-
lated in normal cells, are targeted for de novo methylation in many
human cancers, leading to somatic epigenetic silencing of
transcription [8,9].
As a consequence of the likely differences in transcriptional
regulation, p-class GST expression patterns vary widely across
species, and these expression differences appear to have functional
consequences. As an example, shortly after the discovery of rGST-
P, the rat p-class GST, levels of the enzyme were found to be
stereotypically elevated in preneoplastic hepatic foci, and in
neoplastic lesions, induced by the chemical carcinogens diethylni-
trosamine (DEN) and 2-acetylaminofluorene (AAF) [10]. Because
rGST-P is not expressed in rat hepatocytes under normal
conditions, the appearance of rGST-P-expressing cells has
emerged as a reliable biomarker of hepatocarcinogenesis in the
rat [11,12]. However, this rat model has been difficult to extend to
mice, which exhibit constitutive production of mGstp1/2 in
normal hepatocytes, or to humans, which like rats fail to express p-
class GSTs in hepatocytes, but do not induce p-class GST
expression in preneoplastic or neoplastic lesions [13,14,15,16,
17,18,19]. Of interest, many strains of mice appear much less
susceptible than rats to liver carcinogenesis induced by chemical
carcinogens [5,20].
In an attempt to recapitulate human patterns of p-class GST
expression in mice, we introduced the full-length hGSTP1 gene,
along with its cis-transcriptional regulatory sequences, into the
germline of mice carrying disrupted mGstp genes. The resultant
‘‘humanized’’ strain of hGSTP1+mGstp1/22/2 mice showed
marked differences from wild-type mGstp1/2+/+ mice in the
expression of p-class GSTs in liver tissues, with an absence of the
enzymes in hepatocytes that was reminiscent of the lack of
enzymes in human hepatocytes, but maintenance of expression in
bile duct cells, Kupffer cells, macrophages, and endothelial cells.
These expression differences were responsible for functional
differences in liver toxicology, with hGSTP1+mGstp1/22/2 mice
exhibiting far less liver injury than mGstp1/2+/+ mice upon
administration of high doses of acetaminophen [21]. Nonetheless,
hGSTP1+mGstp1/22/2 mice did manifest limited centrilobular
necrosis not seen in mGstp1/22/2 mice, suggesting that p-class
GSTs remained critical determinants of liver damage even when
not present in hepatocytes.
Results
p-class GST expression in hGSTP1+ mGstp1/22/2 mice
To create humanized hGSTP1+ mGstp1/22/2 mice, a
linearized DNA fragment containing full length hGSTP1 gene
(21138 to +3600) was microinjected into C57BL/6 mouse
oocytes, yielding some 16 offspring. Before attempting to target
this gene to the germline of mice, this construct or a 59 deletion
construct with truncated 59 regulatory regions lacking the
[ATAAA]n pentad repeat (Fig. 1A), was transfected into Hep3B
human liver cancer cells, which are normally devoid of p-class
GSTs as a result of epigenetic silencing of hGSTP1 attributable to
somatic CpG island hypermethylation [16]. hGSTP1 transfection
promoted expression of p-class GST subunit polypeptides and an
increase in GST activity (Fig. 1B–C). Three hGSTP1+ founder
mice were then crossed to C57BL/6 mGstp1/22/2 mice; after
two generations of breeding the resultant hGSTP1+mGstp1/22/2
mouse strain was maintained by breeding with mGstp1/22/2
mice and selecting progeny carrying hGSTP1+ alleles.
hGSTP1+mGstp1/22/2 mice were not grossly different in
appearance or behavior from mGstp1/2+/+ or mGstp1/22/2
mice.
Patterns of p-class GST expression differ substantially
between humans and mice
To ascertain whether human p-class GST expression patterns
were recapitulated in mice by transfer of hGSTP1, with all of its
known cis-regulatory sequences, various tissues from mice and
from humans were subjected to immunohistochemical staining
analyses of enzyme content using anti-p-class GST antibodies
(Fig. 2A). For liver tissues, in mGstp1/2+/+mice, p-class GSTs
were present in the nucleus and cytoplasm of hepatocytes, but not
prominently in Kupffer cells, bile duct cells, and endothelial cells,
while in hGSTP1+ mGstp1/22/2 mice, enzyme expression was
restricted to non-hepatocytes, including endothelial cells, Kupffer
cells, and bile duct cells. In this way, the pattern of p-class GST
expression in human liver, where the hepatocytes are devoid of the
enzymes but show expression in bile duct, endothelial, and
Kupffer cells, was better recapitulated in hGSTP1+mGstp1/22/2
mice than in mGstp1/2+/+mice. Human prostate tissues produce
p-class GSTs predominantly in basal epithelial cells, and much less
so in luminal epithelial cells. As in the liver, this human pattern of
expression was better recapitulated in hGSTP1+mGstp1/22/2
mice than in mGstp1/2+/+mice. Furthermore, the antibodies used
could detect both mouse and human p-class GST with great
specificity, as no immunoreactive peptides were evident in tissues
from mGstp1/22/2 mice.
Next, mRNAs from various tissues from mice and from humans
were subjected to quantitative RT-PCR for mGstp1, hGSTP1,
mGapdh, and hGAPDH (Fig. 2B). In tissues from mature male
C57BL/6 wild type mice, mGstp1 mRNA was present at high levels
in the liver, relative to hGSTP1 mRNA, and expressed at lower
levels in the kidney and in each of the lobes of the prostate. In
contrast, in human tissues, hGSTP1 mRNA, relative to hGAPDH,
was barely detectable in the liver, but expressed at low levels in the
kidney and prostate. For hGSTP1+mGstp1/22/2 mice, hGSTP1
mRNA expression patterns, relative to mGSTP1 mRNA, resem-
bled that of hGSTP1 mRNA, relative to hGAPDH, in human
tissues: hGSTP1 mRNA was nearly absent from the liver while
present in the kidney and in each of the prostate lobes. Of note,
anatomically distinct mouse prostate lobes may be analogous to
non-anatomically distinct human prostate zones, so each of the
mouse lobes were considered independently, while the human
prostate was assessed as a single entity.
GSTP1 CpG island DNA methylation patterns in hGSTP1+
mice
In cancers arising in human liver and human prostate, absence
of p-class GST expression is a consequence of somatic CpG
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hGSTP1 transcriptional regulatory region [8,16]. Remarkably,
though the gene microinjected into mouse oocytes was without
any
5-meC bases, when maintained in the germline, the hGSTP1
alleles present in hGSTP1+ mGstp1/22/2 mice established
patterns of CpG dinucleotide methylation in adult cells that was
similar to those seen in hGSTP1 in normal adult human cells (Fig. 3)
[22]. This suggested that cis-elements in hGSTP1 were not only
sufficient to establish human patterns of hGSTP1 expression in
hGSTP1+ mGstp1/22/2 mice, but also sufficient to establish
human patterns of CpG dinucleotide/CpG island methylation.
Finally, the lack of expression of p-class GSTs in hepatocytes and
prostate luminal cells in hGSTP1+ mGstp1/22/2 mice could not
be explained by hypermethylation of hGSTP1 CpG island
sequences.
Toxicity of acetaminophen (APAP)
Data obtained from in vitro studies using purified enzymes
suggested that p-class GSTs might be major contributors to the
liver disposition of acetaminophen (N-acetyl-p-aminophenol;
APAP) by catalyzing reactions between its reactive metabolite N-
acetyl-p-benzoquinoneimine (NAPQI) and glutathione [23]. How-
ever, when mGstp1/22/2 mice were challenged with an overdose
of acetaminophen (APAP), the mice exhibited a marked decreased,
not increased, hepatotoxicity when compared to mGstp1/2+/+
mice [21]. To ascertain whether in hGSTP1+mGstp1/22/2 mice,
which like mGstp1/22/2 mice, fail to produce p-class GSTs in
hepatocytes, were sensitive or resistant to liver damage caused by
APAP, we treated mGstp1/2+/+ mice, hGSTP1+mGstp1/22/2
mice, and mGstp1/22/2 mice with 300 mg/kg APAP and
assessed the mice for liver damage using serum assays for alanine
aminotransferase (ALT) and histopathology examination of liver
tissues (Fig. 4, 5). Male mGstp1/2+/+ mice that had been fasted for
24 hours and then given APAP by intraperitoneal injection
exhibited marked increases in serum ALT levels relative to
saline-treated controls (p,0.04) and also showed massive centri-
lobular and bridging necrosis in the liver with around 40–50%
hepatocyte death. In contrast, mGstp1/22/2 mice showed very
little evidence of liver damage in response to APAP, and no
significant differences in serum ALT levels. The humanized
hGSTP1+mGstp1/22/2 mice treated with APAP showed low
levels of liver injury, with small serum ALT elevations, more
limited centrilobular necrosis without bridging, and mild hepato-
cellular necrosis (less than 10%). ALT levels were significantly
greater than those observed in the APAP-treated mGstp1/22/2
mice (p=0.03), but lower than wildtype mice. As previously
reported, significant gender differences were observed in response
to the acetaminophen treatment in mGstp1/2+/+ mice. Female
wildtype mice did not show significant elevations in ALT following
acetaminophen treatment relative to saline-treated control. This
gender bias in APAP mediated ALT elevations was also present in
the acetaminophen-treated hGSTP1+mGstp1/22/2 mice,
which also did not show significant elevations in ALT relative to
saline-treated controls. In fact, regardless of genotype, female mice
did not exhibit elevations in ALT following acetaminophen
treatment.
In a second experiment, mice were administered 300 mg/kg
acetaminophen or vehicle by oral gavage in order to more
faithfully model human exposure to the drug. Serum markers of
parenchymal liver damage (as measured by ALT and AST) as well
as biliary duct damage (as measured by alkaline phosphatase and
total bilirubin) were assessed at various timepoints (Fig. 6A). In
wildtype mice levels of ALT and AST increased relative to
baseline measurements 4 hours after drug administration and
peaked at 24 hours. In contrast, mGstp1/2
2/2 mice were
impervious to acetaminophen administration, and serum markers
remained normal. Interestingly, hGSTP1
+mGstp1/2
2/2 mice
exhibited an intermediate level of sensitivity to acetaminophen
relative to the wildtype and mGstp1/2
2/2 mice – elevations of
AST and ALT at 24 hours in hGSTP1+mGstp1/22/2 mice
were significantly greater than those in mGstp1/22/2 mice but
showed a trend to be lower than those seen in wildtype mice
(Figure 6A–B). Acetaminophen treatment did not result in
increases in serum levels of total bilirubin or alkaline phosphate
outside of the normal range, suggesting that acetaminophen-
induced damage was primarily occurring in the hepatocytes.
Figure 1. Full length hGSTP1 directs expression of catalytically-active GSTp. When transfected into Hep3B cells, which do not express
hGSTP1 mRNA or hGSTP1 polypeptides, (A) both full length hGSTP1 (21138 to +3600) and hGSTP1 with [ATAAA]n ([AT]n) repeat sequences deleted
(278 to +3600) directed expression of (B) GSTP1 polypeptides, as detected by immunoblot analysis, and (C) active GSTp, as detected by CDNB assay
using the indicated volumes of HEP3B cell lysates, with appearance of the glutathione conjugate of CDNB monitored as change in OD340 nm. (A–C)
Yellow box, position of [AT]n repeat; Green box, position of CpG island; positions are shown with respect to the hGSTP1 transcriptional start site; blue
boxes, position of exons; rhGSTP1, recombinant human GSTP1 polypeptides in vitro. Transfection controls directed expression of GFP polypeptides.
doi:10.1371/journal.pone.0025707.g001
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The generation of a ‘‘humanized’’ hGSTP1-transgenic mouse
strain has created a new mouse model for the study of human
metabolism, toxicology, and carcinogenesis. The different patterns
of p-class GST expression in mGstp1/2+/+ mice and
hGSTP1+mGstp1/22/2 mice, with accompanying differences in
response to drugs like acetaminophen, may provide new insights
not just into the biochemistry of drug and toxin disposition, but
rather the cell and tissue specific responses to stress and injury
inflicted by such agents. In this way, hGSTP1+mGstp1/22/2 mice
can join an increasing family of ‘‘humanized’’ transgenic mice
created to better understand the xenobiotic metabolism [24].
To make such ‘‘humanized’’ transgenic mice, three general
approaches have been pursued. One technique involves the
construction of transgenes containing cDNA encoding human
metabolizing enzymes ligated to transcription regulatory sequenc-
es to drive cell- or organ-specific enzyme expression. A second
strategy features recombination (or ‘‘knock-in’’) of human coding
sequences into an orthologous mouse gene. For mice generated in
this way, human enzymes can be produced in a mouse pattern of
expression. To create mice in which human enzymes are present
in a human pattern of expression, introduction of the entire
human gene into the germline of mice, as was done for hGSTP1,
may be required. This last approach relies upon the recognition of
human transcriptional regulatory sequences by murine transcrip-
tion factors, which can direct chromatin assembly and lineage-
specific gene expression. For hGSTP1+mGstp1/22/2 mice, the
observed patterns of hGSTP1 expression were most consistent with
significant conservation in transcriptional trans-regulation between
human and mouse. Finally, for any of the ‘‘humanized’’ transgenic
mice producing human enzymes, there is a concern that
simultaneous expression of both human and mouse enzymes
might interfere generally with metabolic processes. The availability
of gene knockout strains, such as mGstp1/22/2 mice, for breeding
crosses with mice carrying human transgenes can reduce this
worry.
One observation made during the expansion of the
hGSTP1+mGstp1/22/2 mouse colony was a general increase in
litter size of the hGSTP1+mGstp1/22/2 mice as compared to
mGstp1/22/2 mice. The mechanistic basis for this difference has
not been established. However, p-class GSTs were originally
assigned the ‘‘P’’ (or ‘‘p’’) family designation because the enzymes
were first found in the placenta [4]. Perhaps, p-class GSTs provide
Figure 2. Regulation of p-class GST expression in hGSTP1+mGstp1/22/2 mice. (A) Immunohistochemistry using anti-GSTp antibodies for
liver and prostate tissues from a wild type mouse, mGstp1/22/2 mouse, hGSTP1+mGstp1/22/2 mouse, and human. Left panels show liver staining;
arrows, bile ducts; V, central vein. Right panels show prostate staining, arrows, representative luminal cells; arrowheads, representative basal cells; Lu,
lumen of prostate gland acini. All images are 2006original magnification. (B) Quantitative RT-PCR for mGstp1 and hGSTP1, normalized to mGapdh or
hGAPDH, using RNA from various tissues.
doi:10.1371/journal.pone.0025707.g002
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mouse or human. This advantage may also be manifest in a
greater than ,60% transmission of the hGSTP1 transgene on the
mGstp1/22/2 background (the expected frequency is 50%). Aside
from the slight increase in litter size and gene transmission, there
were no other obvious gross phenotypes in the hGSTP1+mGstp1/
22/2 mouse strain.
When subjected to APAP overdoses, hGSTP1+mGstp1/22/2
mice responded differently than mGstp1/2+/+ mice. There were
also notable differences between the serum ALT levels of male and
female mice after administration of acetaminophen. This phe-
nomenon is in agreement with previous reports [25,26] and is
likely due to gender-dependent differences in expression of p-class
GSTs; female mice have significantly lower expression of GST-p
and are resistant to damage [21]. Despite intensive study, the
mechanism(s) by which APAP, and APAP metabolism, cause liver
injury has not been fully elucidated. Although APAP can be
converted by cytochrome P450 enzymes to NAPQI, a reactive
intermediate capable of inflicting significant damage, NAPQI can
be detoxified by conjugation to GSH [27,28]. The notion that p-
class GSTs might afford protection against NAPQI generation
from an overdose of APAP was undermined by the finding of a
decrease, rather than increase, in liver injury accompanying APAP
poisoning in mGstp1/22/2 versus mGstp1/+/+ mice, a phenom-
enon confirmed by the current study [21]. Remarkably, between
mGstp1/22/2 and mGstp1/+/+ mice treated with APAP there
were no differences in GSH depletion, though GSH levels
recovered more quickly in mGstp1/22/2 mice. In addition, the
difference in toxicity could not be attributed to differential
expression of enzymes, such as CYP2E1 and other Phase I
enzymes, responsible for the metabolism to acetaminophen to
NAPQI [21,29]. This p-class GST effect on APAP hepatotoxicity
was reflected in the pattern and amount of damage generated by
APAP overdose in hGSTP1+mGstp1/22/2 mice, which express
little, if any p-class GSTs in hepatocytes, but exhibit abundant
expression in bile duct cells, Kupffer cells, macrophages, and
endothelial cells. Taken together, the data strongly suggest that p-
class GSTs act to promote liver injury both by intrinsically
augmenting hepatocyte death when expressed in hepatocytes, and
also by indirectly triggering hepatocyte death when present in
other liver cell types. One possibility for the intrinsic mechanism
may be the influence of p-class GSTs on intracellular signaling
pathways, such as the c-Jun N-terminal kinase (Jnk) pathway
typically activated by cellular stress and proinflammatory cytokines
[30]. In wild-type mice, APAP has been found to trigger prolonged
activation of the Jnk pathway that contributes to hepatocyte death
[31]. mGstp1/22/2 mice have been shown to have significantly
higher basal levels of Jnk signaling compared wild type mice, but
show only modest, if any, increase from this basal signaling after
exposure to acetaminophen [29]. p-class GSTs, encoded by genes
responsive to AP-1 transcription factors (and thus Jnk signaling),
therefore interfere with constitutive Jnk activation, providing an
autoregulatory loop that may be perturbed differently in the
hepatocytes from mGstp1/2+/+, mGstp1/22/2, and
hGSTP1+mGstp1/22/2 mice subjected to the oxidative stress of
APAP overdose, and this may partly underlie the differential levels
of acetaminophen toxicity seen in these mice. The mechanism by
which p-class GSTs present in bile duct cells, Kupffer cells,
Figure 3. The hGSTP1 transgene in hGSTP1+mGstp1/22/2 mice recapitulates the pattern of methylation seen in normal human
cells. Bisulfite genomic sequencing for
5-meC in four amplicons (labeled BiSeq 1–4)from the hGSTP1 CpG island using DNA from various
hGSTP1+mGstp1/22/2 mouse tissues (hGSTP1+ liver, prostate, kidney), along with DNA from human white blood cells (normal hGSTP1
5-meC pattern)
and Hep3B cells (hypermethylated at hGSTP1 CpG island). Each row represents a summary of multiple independently cloned alleles from each sample
as indicated. Circles indicate the relative position of CpG dinucleotides within the bisulfite sequencing amplicon. The color of each circle is scaled to
the fraction of alleles methylated for the indicated CpG according to the heatmap shown at the bottom.
doi:10.1371/journal.pone.0025707.g003
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ular necrosis in hepatocytes devoid of the enzyme is less clear.
Nonetheless, centrilobular necrosis constitutes a common mode of
human liver injury in response to liver toxin exposure. Perhaps,
hGSTP1+mGstp1/22/2 mice may better model this type of liver
response to toxins than wild-type mouse strains which contain high
levels of p-class GSTs in hepatocytes.
Finally, the availability of hGSTP1+mGstp1/22/2 mice may
permit new studies of carcinogenesis that better recapitulate
human cancer development. By comparing responses of mGstp1/
2+/+ and Gstp1/22/2 mice to chemical carcinogens, p-class
GSTs have been implicated in protection against tumor
development in several different organ sites, including the skin,
the colon, and the lungs [32,33,34]. For human cancers, the
contributions of p-class GSTs appear to be more complex. During
the pathogenesis of some human cancers, such as cancers of the
colon, lung, kidney, and stomach, hGSTP1 has been reported to
be expressed at high levels and contribute to anti-neoplastic drug
resistance [14,35]. In other human cancers, such as cancers of the
prostate, liver, and breast, hGSTP1 is conspicuously absent
[8,16,36]. Absence of hGSTP1 expression appears mostly
attributable to somatic epigenetic hGSTP1 silencing attributable
to de novo changes in DNA methylation at a CpG island
encompassing the gene promoter. Epigenetic silencing of p-class
GST expression has not been reported for either mGstp1/2 or for
rGST-P. Since hGSTP1 contains a much higher density of CpG
dinucleotides than either of the rodent orthologs, perhaps hGSTP1
may be more vulnerable than mGstp1/2 or for rGST-P to
epigenetic silencing during carcinogenesis. This hypothesis can
be tested using hGSTP1+mGstp1/22/2 mice, which have
established both a more human pattern of hGSTP1 expression
in the liver and prostate and a human pattern of
5-meCpG
distribution at the hGSTP1 CpG island.
Materials and Methods
Ethics Statement
Animal Studies. All experimental protocols were approved
and performed in accordance with the standards established by the
U.S. Animal Welfare Acts, as set forth in the National Institutes of
Health guidelines and in the Policy and Procedures Manual of the
Johns Hopkins University Animal Care and Use Committee
(Approval Numbers MO10M447, MO08M163, MO08M465,
MO08M487).
Human Samples. Human tissues and nucleic acids were
obtained and used following protocols and guidelines approved by
the Johns Hopkins University Institutional Review Board (Study
number: NA_00048544). For bisulfite sequencing analysis, human
male genomic DNA was obtained from Novagen (Cat # 70572).
Generation of hGSTP1 transgenic mice
The full length hGSTP1 gene (21138 to +3600) was amplified
from a bacterial artificial chromosome (BAC) containing sequence
from chromosome 11q (accession number AP001184; from
Figure 4. APAP-induced liver injury in male and female wild type, mGstp1/22/2, and hGSTP1+mGstp1/22/2 mice. Serum ALT levels
24 hours after intraperitoneal injection of 300 mg/kg APAP or saline are shown. Compared to mGstp1/22/2 mice, mGstp1/2+/+ (p,0.04) and
hGSTP1+mGstp1/22/2 (p,0.03) mice exhibited significantly higher ALT elevations in response to APAP overdose. Data was analyzed by Wilcoxon
Rank Sum test.
doi:10.1371/journal.pone.0025707.g004
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Oakland Research Institute , Oakland, CA) using PfuUltra
polymerase (Stratagene). A plasmid containing full length hGSTP1,
along with a plasmid that had the 59 [ATAAA]n repeat sequences
deleted (278 to +3600), were transfected into Hep3B cells, known
to be devoid of hGSTP1 mRNA and hGSTP1 polypeptides as a
result of epigenetic hGSTP1 silencing, to ensure that the gene was
capable of directing expression of catalytically-active GSTp [16].
Transfection was accomplished using Lipofectamine Plus (Invitro-
gen) in serum free minimal essential medium (MEM). The full
length hGSTP1-containing construct was then provided to
Xenogen (Hopkinton, MA) for pronuclear microinjection and
development of the founder mice on a C57BL/6 strain
background. To identify hGSTP1+ progeny, genotyping specifi-
cally for hGSTP1, even in the presence of wild type mouse DNA,
was accomplished by PCR using the forward primer 59-
AGGCGTGCAGATCACCTAAG-39 and the reverse primer
59- GCCACATCTGGCTGATTTTT-39 with cycling conditions
of 95uC for 3 minutes, 35 cycles of 95uC for 30 seconds, 59uC for
30 seconds, and 72uC for 45 seconds, yielding a 100 base pair
product.
Breeding to create hGSTP1+Gstp1/22/2 mice
All mice were housed in a pathogen-free environment, allowed
free access to food and water, and were maintained on a 12 hour
light/dark cycle. mGstp1/22/2 that had been extensively
backcrossed to C57BL/6 mice were available for breeding crosses
with hGSTP1+ mice. Genotyping for mGstp1/2+/+ and mGstp1/
22/2 was performed using the same PCR reaction conditions as
for hGSTP1, but with the following primers: mGstp1/2+/+ forward
59-GGCCACCCAACTACTGTGAT -39, mGstp1/2+/+ reverse
59-AGAAGGCCAGGTCCTAAAGC -39, mGstp1/22/2 forward
Figure 5. Histopathology of liver tissues from APAP-treated wild type, mGstp1/22/2, and hGSTP1+mGstp1/22/2 mice. Arrowheads
denote central veins; arrows highlight liver injury/necrosis. Left panels are 2006 original magnification and Right panels are 4006 original
magnification.
doi:10.1371/journal.pone.0025707.g005
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reverse 59-ATGGCGATTACCGTTGATGT -39. To assess patterns
of p-class GST expression and DNA methylation, mice were
euthanized in a CO2 chamber according to Johns Hopkins Animal
Care and Use Committee (ACUC) guidelines. After sacrifice, tissues
were harvested and immediately placed in formalin or snap frozen in
liquid nitrogen for further processing.
Assessment of p-class GST expression by quantitative RT-
PCR, immunoblot analysis, immunohistochemistry, and
enzyme activity assay
RNA isolated from various human and mouse tissues was
assayed for the expression of specific mRNAs using a QuantiTect
Probe RT-PCR Kit (Qiagen, Valencia, CA) and primer sets for
hGSTP1, hGAPDH, mGstp1, mGstp2, and mGAPDH from Applied
Figure 6. Acetaminophen-induced hepatic injury in male wildtype, mGstp1/22/2, and hGSTP+mGstp1/22/2 mice. Baseline serum
measurements were taken prior to administration of the drug. Mice were fasted for 12 or 24 hours and then administered vehicle or 300 mg/kg
acetaminophen via gavage. (A) Serum AST, ALT, ALP and total bilirubin measurements taken in serum collected at 4, 24, and 48 hours. (B) Serum
measurements of AST and ALT at 24 hours after acetaminophen administration. N=5 mice per group *=p,0.05 by Students t-test.
doi:10.1371/journal.pone.0025707.g006
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expression was detected in protein lysates from cells and tissues by
immunoblot analysis with anti-GSTp antibodies as previously
described [8]; GST activity in the lysates was monitored using 1-
chloro-2,4-dinitrobenzene (CDNB) as a substrate, with recombi-
nant human GSTp (Calbiochem) as a positive control [37].
Human and mouse tissues were evaluated for patterns of p-class
GST expression via immunohistochemical staining of formalin
fixed, paraffin embedded, tissue sections. Briefly, the sections were
deparaffinized by rinsing in xylene and then in a gradient of
ethanols (100%R70%) until clear; antigen retrieval was accom-
plished by citrate steaming for 20 minutes. After incubating for
5 minutes in hydrogen peroxide and rinsed, the slides were probed
with anti-GSTp antibody (Stressgen, Ann Arbor, MI) at a 1:1500
dilution, overnight at 4uC. Antibody binding was revealed using a
horseradish peroxidase-conjugated secondary antibody (Dako,
Denmark) applied to tissue sections for 30 minutes. For color
generation and counterstaining, slides were first incubated in
diaminobenzidine (Sigma), and then in hematoxylin (Dako).
Bisulfite genomic sequencing for assessment of hGSTP1
CpG island methylation
Sequence mapping of
5-meC bases at the hGSTP1 CpG island
was undertaken using bisulfite conversion methods and PCR
primers for four amplicons as described by Millar et al. [22].
Toxicology analyses. Mice were administered acetamino-
phen (N-acetyl-p-aminophenol; APAP; Sigma) via intraperitoneal
(IP) injection or via oral gavage. APAP was used at a concentration
of 300 mg/kg in phosphate buffered saline (PBS) and injections
were undertaken using mice that were fasted for 12 hours prior to
injection. Acetaminophen dosage was selected based on previous
reports of hepatotoxicity in mice [21,38]. To assess the injurious
effects of APAP on liver histology and function, serum was
collected from mice via submandibular venipuncture or cardiac
puncture (at terminal timepoints). Serum samples were taken at 4,
24, and 48 hours after gavage. Mice were sacrificed via cardiac
puncture/exsanguination following administration of 14 mg
Avertin (20 mg/ml, Sigma) or via CO2 asphyxiation. The blood
was collected in BD Microtainer SST tubes (BD, Franklin Lakes,
NJ), allowed to clot for at least 1 hour at room temperature, and
then centrifuged at 16,0006 g for 2 minutes at 4uC to allow
separation of serum. Serum specimens were assayed for alanine
aminotransferase (ALT), aspartate aminotransferase (AST), alka-
line phosphatase (ALP) and total bilirubin levels using VetAce
(Alfa Wassermann, West Caldwell, NJ). For histopathology,
dissected liver tissues were fixed in buffered formalin, embedded
in paraffin, and then processed for tissue section staining with
hematoxylin and eosin.
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